Establishing Germ Cell Fate in Xenopus
Establishing Germ Cell Fate in Xenopus
批准号:
6331219
负责人:
MARY LOU KING
金额:
$34.42万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-08-01 至 2005-03-31
关键词:
Xenopus Xenopus oocyte cell differentiation cell migration developmental genetics early embryonic stage embryogenesis embryonic stem cell endoderm gametogenesis gene expression genetic translation germ cells green fluorescent proteins immunocytochemistry in situ hybridization microinjections molecular polarity nonmammalian vertebrate embryology oogenesis pluripotent stem cells protein biosynthesis protein structure function transcription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant)
In sexually reproducing species, gametes are the only cells in the body that
can give rise to a genetically complete new organism. In this sense, "gametes
are the stem cells of the species" (Wylie, 1999). Gametes originate from a
small population of cells called primordial germ cells (PGCs) that form early
in development. These unique cells retain full totipotency while somatic cells
become progressively restricted in their fates. Eventually, PGCs migrate from
their site of origin to the somatic gonads where they divide, enter meiosis and
sexually differentiate. In Xenopus, it is thought that PGCs are determined by
inheritance of germ plasm, a specialized cytoplasmic domain containing unique
RNAs and proteins. Virtually nothing is known about how PGCs preserve their
totipotency or what functions germ plasm components play in POC development.
Several germ plasm specific RNAs have been isolated, including Xdazl a member
of the DAZ family in humans (King et al., 1999). We found that maternal
depletion of Xdazl results in the severe reduction or loss of PGCs because they
fail to migrate out of the endoderm (Houston and King, 2000). Xcat-2,
DEADSouth, and Xpat are other germ plasm specific RNAs that have been
characterized, but whose functions are not known. In this proposal, experiments
are outlined to explore how germ cell fate is determined and will address the
following questions: I. What mechanism permits PGCs to retain a totipotent fate
while surrounding cells in the vegetal mass become committed to an endoderm
fate? What role, if any, does endoderm play in this process? II. What steps in
PGC development require the germ plasm components Xcat-2, DEADSouth, Xdazl, and
Xpat? What specific molecular functions do Xdazl and DEADSouth proteins
perform? III. What is the mechanism of translational repression of the germ
plasm RNAs Xdazl, Xcat2, and DEADSouth during oogenesis?
A method for targeting green fluorescent protein (GFP) expression to the germ
plasm is presented that will allow PGCs to be followed or isolated at different
times in development. This procedure will make PGCs accessible to biochemical
and molecular studies for the first time. Immunocytochemistry and in situ
hybridization will be used to determine when PGCs become transcriptionally
active and whether they express genes diagnostic for endoderm.
Gain-of-function, loss-of-function, and over-expression experiments targeting
the germ plasm RNAs will pinpoint the steps that require these genes. Oocyte
injections of deletion mutants in the UTR regions of Xcat2 and Xdazl will
reveal cis-acting elements required for translational repression. These cis
elements will be used to affinity purify trans-acting factors. Results from
these proposed studies will offer significant insights into how the germline
forms in Xenopus and in general as key aspects of PGC development (totipotency,
migration) are likely conserved across phyla.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Translational Regulators Nanos and Dazl in Preserving Totipotency
-
批准号:8506391
-
项目类别:
-
资助金额:$36.82万
-
财政年份:2013
-
负责人:MARY LOU KING
-
依托单位:
Role of Translational Regulators Nanos and Dazl in Preserving Totipotency
-
批准号:8636488
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2013
-
负责人:MARY LOU KING
-
依托单位:
IDENTIFYING GERMLINE GENES AS TARGETS FOR THERAPEUTIC INTERVENTION IN CANCER
-
批准号:8445954
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2012
-
负责人:MARY LOU KING
-
依托单位:
IDENTIFYING GERMLINE GENES AS TARGETS FOR THERAPEUTIC INTERVENTION IN CANCER
-
批准号:8554776
-
项目类别:
-
资助金额:$14.52万
-
财政年份:2012
-
负责人:MARY LOU KING
-
依托单位:
Establishing Germ Cell Fate in Xenopus
-
批准号:7988443
-
项目类别:
-
资助金额:$13.27万
-
财政年份:2009
-
负责人:MARY LOU KING
-
依托单位:
LOCALIZED RNAS--DORSAL AND GERM CELL DETERMINANTS
-
批准号:2177197
-
项目类别:
-
资助金额:$26.17万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
CHARACTERIZATION OF LOCALIZED MATERNAL MRNA
-
批准号:3284139
-
项目类别:
-
资助金额:$10.35万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
LOCALIZED MATERNAL MRNA
-
批准号:2177195
-
项目类别:
-
资助金额:$24.45万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
LOCALIZED MATERNAL MRNA
-
批准号:2177196
-
项目类别:
-
资助金额:$25.54万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
Establishing Germ Cell Fate in Xenopus
-
批准号:6709397
-
项目类别:
-
资助金额:$32.57万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
CHARACTERIZATION OF LOCALIZED MATERNAL MRNA
-
批准号:3284140
-
项目类别:
-
资助金额:$23.74万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
CHARACTERIZATION OF LOCALIZED MATERNAL MRNA
-
批准号:3284138
-
项目类别:
-
资助金额:$10.52万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
CHARACTERIZATION OF LOCALIZED MATERNAL MRNA
-
批准号:3284134
-
项目类别:
-
资助金额:$22.08万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
LOCALIZED RNAS--DORSAL AND GERM CELL DETERMINANTS
-
批准号:2444582
-
项目类别:
-
资助金额:$25.71万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
Establishing Germ Cell Fate in Xenopus
-
批准号:7448442
-
项目类别:
-
资助金额:$34.91万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
CHARACTERIZATION OF LOCALIZED MATERNAL MRNA
-
批准号:3284141
-
项目类别:
-
资助金额:$5.83万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
Establishing Germ Cell Fate in Xenopus
-
批准号:7144675
-
项目类别:
-
资助金额:$34.31万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
Establishing Germ Cell Fate in Xenopus
-
批准号:7633327
-
项目类别:
-
资助金额:$34.91万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
Establishing Germ Cell Fate in Xenopus
-
批准号:6635913
-
项目类别:
-
资助金额:$32.57万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
Establishing Germ Cell Fate in Xenopus
-
批准号:7247937
-
项目类别:
-
资助金额:$34.91万
-
财政年份:1988
-
负责人:MARY LOU KING
-
依托单位:
海外基金